Nephros Profit Margin

Nephros (NEPH) currently reports a profit margin of 4.06% as of March 2026. That compares with 5.16% in the prior-year period — down 21.4% year over year. That is below the Healthcare sector average of 15.52%. Use the charts on this page to explore Nephros's profit margin history and peer comparisons.

Nephros's profit margin decreased from 5.16% to 4.06% — a 21.4% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Nephros's profit margin of 4.06% is lower than the Healthcare sector average of 15.52%. That is roughly 73.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Nephros's current 4.06% should be judged against Healthcare norms (sector average: 15.52%) and against NEPH's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 4.06%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.52%. From there, open related valuation or income-statement pages for Nephros, and consider following NEPH for alerts when major investors trade the stock.